is a tirzepatide better than a semaglutide and key differences, weight loss results (2026) Tirzepatide vs. Semaglutide for Weight

They add no value

CagriSema , Novo Nordisks co-formulation of semaglutide 2.4mg and the long-acting amylin analogue cagrilintide, demonstrated 22.7% body weight reduction in the REDEFINE-1 Phase 3 trial substantially exceeding standalone semaglutide and positioning Novo Nordisk to defend GLP-1 market leadership against tirzepatides superior weight loss profile

However, Wegovy should only be used under the supervision of a healthcare provider who will review it with you and then monitor the risks and benefits of including Wegovy in your weight management program

However, its role has expanded, gaining popularity for weight loss capabilities

Overall, its important to examine risks and benefits for each person individually